- Report
- February 2022
- 74 Pages
Global
From €1781EUR$2,000USD£1,553GBP
- Report
- February 2022
- 37 Pages
Global
From €1781EUR$2,000USD£1,553GBP
- Report
- February 2022
- 36 Pages
Global
From €1781EUR$2,000USD£1,553GBP
- Report
- February 2022
- 80 Pages
Global
From €1781EUR$2,000USD£1,553GBP
- Drug Pipelines
- March 2021
Global
From €2226EUR$2,500USD£1,941GBP
- Drug Pipelines
- March 2021
Global
From €3117EUR$3,500USD£2,718GBP
- Drug Pipelines
- March 2021
Global
From €1781EUR$2,000USD£1,553GBP
- Report
- April 2025
- 73 Pages
Global
From €8901EUR$9,995USD£7,762GBP
- Report
- March 2022
- 155 Pages
Global
From €3963EUR$4,450USD£3,456GBP
- Report
- April 2024
- 123 Pages
Global
From €3518EUR$3,950USD£3,067GBP
- Report
- February 2025
- 149 Pages
Global
From €3518EUR$3,950USD£3,067GBP
- Report
- January 2025
- 141 Pages
Global
From €3518EUR$3,950USD£3,067GBP
- Report
- January 2025
- 140 Pages
Global
From €3518EUR$3,950USD£3,067GBP
- Report
- December 2023
- 145 Pages
Global
From €3963EUR$4,450USD£3,456GBP
- Report
- December 2022
- 102 Pages
Africa, Middle East
From €1336EUR$1,500USD£1,165GBP
- Report
- December 2022
- 102 Pages
Europe
From €1336EUR$1,500USD£1,165GBP
- Report
- December 2022
- 283 Pages
Global
From €3206EUR$3,600USD£2,796GBP
- Report
- December 2022
- 102 Pages
Asia Pacific
From €1336EUR$1,500USD£1,165GBP
- Report
- December 2022
- 88 Pages
North America
From €1336EUR$1,500USD£1,165GBP
- Report
- January 2022
- 233 Pages
Global
From €3206EUR$3,600USD£2,796GBP

The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs.
The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more